Cục Thông tin KH&CN Quốc gia trân trọng kính gửi đến các nhà khoa học những nghiên cứu mới nhất về COVID-19 trên thế giới. Bao gồm những bài viết đã được xuất bản chính thức và các bài viết được chấp nhận đăng trên những cơ sở dữ liệu học thuật chính thống từ ngày 10/9 đến ngày 17/92021. Những nghiên cứu công bố trước thời gian này được tổng hợp tại đường link cuối bài.

SCIENCEDIRECT

1. Prediction of False-Positive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Molecular Results in a High-Throughput Open-Platform System

The Journal of Molecular Diagnostics, 8 June 2021, Volume 23, Issue 9, Pages 1085-1096

Ryan J. Martinez, Nathan Pankratz, Andrew C. Nelson

https://www.sciencedirect.com/science/article/pii/S1525157821001665/pdfft?md5=65d7f7726a5815c6545c341dc204e624&pid=1-s2.0-S1525157821001665-main.pdf

2. COVID-19 vaccines: Current evidence and considerations

Metabolism Open, 11 September 2021, Volume 12, Article 100124

Alireza Tavilani, Ebrahim Abbasi, Zahra Asefy

https://www.sciencedirect.com/science/article/pii/S2589936821000487/pdfft?md5=d3cbfd1ab495b540cb8f230447d21241&pid=1-s2.0-S2589936821000487-main.pdf

3. Design and application of nanoparticles as vaccine adjuvants against human corona virus infection

Journal of Inorganic Biochemistry, 29 March 2021, Volume 219, Article 111454

Lichun Mao, Ziwei Chen, Chunying Chen

https://www.sciencedirect.com/science/article/pii/S016201342100101X

4. Towards a novel peptide vaccine for Middle East respiratory syndrome coronavirus and its possible use against pandemic COVID-19

Journal of Molecular Liquids, 6 November 2020, Volume 324, Article 114706

Salman Khan, Bilal Shaker, Wasim Sajjad

https://www.sciencedirect.com/science/article/abs/pii/S0167732220369488

5. Vaccine hesitancy among people with multiple sclerosis

Multiple Sclerosis and Related Disorders, 2 September 202, Volume 56, Article 103236

Siew Mei Yap, Mahmood Al Hinai, Christopher McGuigan

https://www.sciencedirect.com/science/article/abs/pii/S2211034821005034

6. A comprehensive analysis of the efficacy and safety of COVID-19 vaccines

Molecular Therapy, 6 August 2021, Volume 29, Issue 9, Pages 2794-2805

Changjing Cai, Yinghui Peng, Hong Shen

https://www.sciencedirect.com/science/article/pii/S1525001621003956/pdfft?md5=d076570807615680fdeba6a50a146c59&pid=1-s2.0-S1525001621003956-main.pdf

7. The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis

The Journal of Allergy and Clinical Immunology: In Practice, 20 April 2021, Volume 9, Issue 7, Pages 2556-2561

Marcus Shaker, Elizabeth Phillips, Matthew Greenhawt

https://www.sciencedirect.com/science/article/abs/pii/S2213219821004554

8. Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19

Molecular Therapy, 23 April 2021, Volume 29, Issue 8, Pages 2412-2423

Stefania Capone, Angelo Raggioli, Alessandra Vitelli

https://www.sciencedirect.com/science/article/abs/pii/S1525001621002100

9. In-silico immunoinformatic analysis of SARS-CoV-2 virus for the development of putative vaccine construct

Immunobiology, 28 August 2021, Volume 226, Issue 5, Article 152134

Abhishek Sharma, Surinder Pal, Ashok Kumar

https://www.sciencedirect.com/science/article/pii/S0171298521000826/pdfft?md5=9abb72568b71bf6d665d5d2f7315c7a5&pid=1-s2.0-S0171298521000826-main.pdf

10. Evaluation of Covid-19 vaccines: Pharmacoepidemiological aspects

Therapies, 7 May 2021, Volume 76, Issue 4, Pages 305-309

Antoine Pariente, Julien Bezin

https://www.sciencedirect.com/science/article/abs/pii/S0040595721001165

11. Protective heterologous T cell immunity in COVID-19 induced by the trivalent MMR and Tdap vaccine antigens

Med, 14 August 2021, Volume 2, Issue 9, Pages 1050-1071.e7

Vijayashree Mysore, Xavier Cullere, Tanya N. Mayadas

https://www.sciencedirect.com/science/article/pii/S2666634021002890/pdfft?md5=a943122b2d981b03101200c907da24e9&pid=1-s2.0-S2666634021002890-main.pdf

12. First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing

The Journal of Allergy and Clinical Immunology: In Practice, 22 June 2021, Volume 9, Issue 9, Pages 3308-3320.e3

Anna R. Wolfson, Lacey B. Robinson, Aleena Banerji

https://www.sciencedirect.com/science/article/pii/S2213219821006759/pdfft?md5=ec760d227d1ee85e50f3436e4d8d7336&pid=1-s2.0-S2213219821006759-main.pdf

13. Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity

Journal of Allergy and Clinical Immunology, 1 June 2021, Volume 148, Issue 3, Pages 739-749

David Hagin, Tal Freund, Natalia T. Freund

https://www.sciencedirect.com/science/article/abs/pii/S0091674921008873

14. Cutaneous adverse effects of the available COVID-19 vaccines

Clinics in Dermatology, 27 April 2021, Volume 39, Issue 3, Pages 523-531

Georgi Bogdanov, Ivan Bogdanov, Nikolai Tsankov

https://www.sciencedirect.com/science/article/abs/pii/S0738081X21000614

15. An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates

Cell Host & Microbe, 7 August 2021, Volume 29, Issue 9,Pages 1437-1453.e8

Nerea Zabaleta, Wenlong Dai, Luk H. Vandenberghe

https://www.sciencedirect.com/science/article/pii/S1931312821003784/pdfft?md5=e75f3d4cf120e3e07827846375737f54&pid=1-s2.0-S1931312821003784-main.pdf

16. Diabetes and COVID-19: Mechanism of pneumonia, treatment strategy and vaccine

Metabolism Open, 7 September 2021, Volume 11, Article 100122

Ebrahim Abbasi, Fatemeh Mirzaei, Iraj Khodadadi

https://www.sciencedirect.com/science/article/pii/S2589936821000463/pdfft?md5=271e91010470ed3d35f53a7f47662a02&pid=1-s2.0-S2589936821000463-main.pdf

17. Inverted repeats in coronavirus SARS-CoV-2 genome manifest the evolution events

Journal of Theoretical Biology, 31 August 2021, Volume 530, Article 110885

Changchuan Yin, Stephen S. -T. Yau

https://www.sciencedirect.com/science/article/pii/S0022519321003040/pdfft?md5=49b80f85d1a0c01e84ba96cbec3d92ce&pid=1-s2.0-S0022519321003040-main.pdf

18. Epidemiological feature, viral shedding, and antibody seroconversion among asymptomatic SARS-CoV-2 carriers and symptomatic/presymptomatic COVID-19 patients

Journal of Infection and Public Health, 27 May 2021, Volume 14, Issue 7, Pages 845-851

Yi Chen, Ping Li, Guangwen Cao

https://www.sciencedirect.com/science/article/pii/S1876034121001209/pdfft?md5=bdade96d3619231279ecc4f4bd321445&pid=1-s2.0-S1876034121001209-main.pdf

19. Estimation of the main conditions in (SARS-CoV-2) Covid-19 patients that increase the risk of death using Machine learning, the case of Mexico

Results in Physics, 24 June 2021, Volume 27, Article 104483

José A. Guzmán-Torres, Elia M. Alonso-Guzmán, Gerardo Tinoco-Guerrero

https://www.sciencedirect.com/science/article/pii/S2211379721005969/pdfft?md5=2512bc2da776a96993c51543b81ae321&pid=1-s2.0-S2211379721005969-main.pdf

20. A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations

Cell Reports, 7 July 2021, Volume 36, Issue 4, Article 109433

Federico Bertoglio, Viola Fühner, Michael Hust

https://www.sciencedirect.com/science/article/pii/S2211124721008500/pdfft?md5=f9fab3f4384354dfa777a407482ae703&pid=1-s2.0-S2211124721008500-main.pdf

21. Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19

Journal of Allergy and Clinical Immunology, 20 November 2020, Volume 147, Issue 2, Pages 545-557.e9

Carlo Cervia, Jakob Nilsson, Onur Boyman

https://www.sciencedirect.com/science/article/pii/S0091674920316237/pdfft?md5=729ef0351cea7453f557486bd7a85494&pid=1-s2.0-S0091674920316237-main.pdf

22. Reactivation of SARS-CoV-2 infection following recovery from COVID-19

Journal of Infection and Public Health, 8 February 2021, Volume 14, Issue 5, Pages 620-627

Zhihai Chen, Wen Xie, Calvin Q. Pan

https://www.sciencedirect.com/science/article/pii/S1876034121000320/pdfft?md5=449b1fc4bc1fbaaaf6f6dce52eff7426&pid=1-s2.0-S1876034121000320-main.pdf

23. Systems level insights into the impact of airborne exposure on SARS-CoV-2 pathogenesis and COVID-19 outcome – A multi-omics big data study

Gene Reports, 12 August 2021, Volume 25, Article 101312

Jeganathan Manivannan, Lakshmikirupa Sundaresan

https://www.sciencedirect.com/science/article/pii/S2452014421002971/pdfft?md5=91ab2db645c883d03651abb4c730cffb&pid=1-s2.0-S2452014421002971-main.pdf

24. Decrypting the role of predicted SARS-CoV-2 miRNAs in COVID-19 pathogenesis: A bioinformatics approach

Computers in Biology and Medicine, 21 July 2021, Volume 136, Article 104669

Motiur Rahaman, Jaikrishna Komanapalli, Nishant Chakravorty

https://www.sciencedirect.com/science/article/pii/S0010482521004637/pdfft?md5=8f248c3828bf0c627eb89fcee1263fc8&pid=1-s2.0-S0010482521004637-main.pdf

25. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19

Cell, 23 July 2021, Volume 184, Issue 18, Pages 4713-4733.e22

Carly G. K. Ziegler, Vincent N. Miao, Jose Ordovas-Montanes

https://www.sciencedirect.com/science/article/pii/S0092867421008825/pdfft?md5=c1afdb44fc87ddcbef3fd4e9c0eb3776&pid=1-s2.0-S0092867421008825-main.pdf

26. Stochastic modelling of the dynamics of infections caused by the SARS-CoV-2 and COVID-19 under various conditions of lockdown, quarantine, and testing

Results in Physics, 24 July 2021, Volume 28, Article 104573

Tiri Chinyoka

https://www.sciencedirect.com/science/article/pii/S2211379721006732/pdfft?md5=a7abd6a3f54d858f621bcb4a9b2f2aa1&pid=1-s2.0-S2211379721006732-main.pdf

27. Adaptive immune responses to SARS-CoV-2 in recovered severe COVID-19 patients

Journal of Clinical Virology, 8 August 2021, Volume 142, Article 104943

Beatriz Olea, Eliseo Albert, David Navarro

https://www.sciencedirect.com/science/article/pii/S1386653221002109/pdfft?md5=60c98ff36f4fbc22b3ab875f939e4a79&pid=1-s2.0-S1386653221002109-main.pdf

28. Tissue-based SARS-CoV-2 detection in fatal COVID-19 infections: Sustained direct viral-induced damage is not necessary to drive disease progression

Human Pathology, 4 May 2021, Volume 114, Pages 110-119

Siraj M. El Jamal, Elisabet Pujadas, William H. Westra

https://www.sciencedirect.com/science/article/pii/S0046817721000708/pdfft?md5=320c51494446b2d1aff7336157d0d3b0&pid=1-s2.0-S0046817721000708-main.pdf

29. Topological Analysis for Sequence Variability: Case Study on more than 2K SARS-CoV-2 sequences of COVID-19 infected 54 countries in comparison with SARS-CoV-1 and MERS-CoV

Infection, Genetics and Evolution, 6 January 2021, Volume 88, Article 104708

Jnanendra Prasad Sarkar, Indrajit Saha, Ujjwal Maulik

https://www.sciencedirect.com/science/article/abs/pii/S1567134821000058

30. Isothermal recombinase polymerase amplification-lateral flow detection of SARS-CoV-2, the etiological agent of COVID-19

Journal of Virological Methods, 2 July 2021, Volume 296, Article 114227

Thomas R. Shelite, Ashanti C. Uscanga-Palomeque, Bruno L. Travi

https://www.sciencedirect.com/science/article/pii/S016609342100166X/pdfft?md5=0846a05d74599c03f44be4a5351f4de9&pid=1-s2.0-S016609342100166X-main.pdf

31. Assessment of adjuvantation strategy of lipid squalene nanoparticles for enhancing the immunogenicity of a SARS-CoV-2 spike subunit protein against COVID-19

International Journal of Pharmaceutics, 18 August 2021, Volume 607, Article 121024

Hui-Min Ho, Chiung-Yi Huang, Ming-Hsi Huang

https://www.sciencedirect.com/science/article/pii/S0378517321008309/pdfft?md5=726c5d3dc595e569e1b3a5e0c7147b74&pid=1-s2.0-S0378517321008309-main.pdf

32. Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents

Journal of Ethnopharmacology, 5 June 2021, Volume 278, Article 114303

Jie Mei, Yatong Zhou, Boyang Yu

https://www.sciencedirect.com/science/article/abs/pii/S0378874121005304

33. Investigation of beta-lactoglobulin derived bioactive peptides against SARS-CoV-2 (COVID-19): In silico analysis

European Journal of Pharmacology, 1 December 2020, Volume 891, Article 173781

Bilal Çakır, Betul Okuyan, Tugba Tunali-Akbay

https://www.sciencedirect.com/science/article/abs/pii/S0014299920308736

34. Predicting mortality in SARS-COV-2 (COVID-19) positive patients in the inpatient setting using a novel deep neural network

International Journal of Medical Informatics, 21 August 2021, Volume 154, Article 104556

Maleeha Naseem, Hajra Arshad, Fahad Shabbir Ahmed

https://www.sciencedirect.com/science/article/pii/S1386505621001829/pdfft?md5=8bb31f1f90f4f7494a9b3692da503c19&pid=1-s2.0-S1386505621001829-main.pdf

35. Alveolar epithelial cell type II as main target of SARS-CoV-2 virus and COVID-19 development via NF-Kb pathway deregulation: A physio-pathological theory

Medical Hypotheses, 23 November 2020, Volume 146, Article 110412

Maurizio Carcaterra, Cristina Caruso

https://www.sciencedirect.com/science/article/abs/pii/S030698772033303X

36. SARS-CoV-2/COVID-19 in multiple sclerosis patients receiving disease-modifying therapy

Clinical Neurology and Neurosurgery, 29 December 2020, Volume 201 (Cover date: February 2021), Article 106451

Monika Adamczyk-Sowa, Hubert Mado, Paweł Sowa

https://www.sciencedirect.com/science/article/abs/pii/S0303846720307940

37. Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)

Annals of Hepatology, 21 October 2020, Volume 20 (Cover date: January–February 2021), Article 100271

Ivan Lopez-Mendez, Jorge Aquino-Matus, Graciela Castro-Narro

https://www.sciencedirect.com/science/article/pii/S1665268120301861/pdfft?md5=654d61c88b8d5e0debb55e1f5054a699&pid=1-s2.0-S1665268120301861-main.pdf

38. Neurological complications associated with coronavirus disease-2019 (COVID-19): MRI features

Heliyon, 26 August 2021, Volume 7, Issue 8, Article e07879

Neven Moustafa Hazzaa

https://www.sciencedirect.com/science/article/pii/S2405844021019824/pdfft?md5=3e6bb4eab7252082ec0d218f5a058f50&pid=1-s2.0-S2405844021019824-main.pdf

39. SARS-CoV-2 assessment in an outpatient dialysis facility of a single center in Brazil

The Brazilian Journal of Infectious Diseases, May–June 2021, Volume 25, Issue 3, Article 101595

Fernanda Salomão Gorayeb-Polacchini, Heloisa Cristina Caldas, Mario Abbud-Filho

https://www.sciencedirect.com/science/article/pii/S1413867021000647/pdfft?md5=a6e4ffadd4d3be7ea2d4da2fd4072f16&pid=1-s2.0-S1413867021000647-main.pdf

40. Comparison of Two Commercial Platforms and a Laboratory-Developed Test for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA

The Journal of Molecular Diagnostics, 21 January 2021, Volume 23, Issue 4, Pages 407-416

Laura Mannonen, Hannimari Kallio-Kokko, Maija Lappalainen

https://www.sciencedirect.com/science/article/pii/S1525157821000076/pdfft?md5=3cdc80551dd49d7207948473f5a701ee&pid=1-s2.0-S1525157821000076-main.pdf

41. Preoperative Chest Computed Tomography Screening for Coronavirus Disease 2019 in Asymptomatic Patients Undergoing Cardiac Surgery

Seminars in Thoracic and Cardiovascular Surgery, 17 October 2020, Volume 33, Issue 2, Pages 417-424

Wiebe G. Knol, Daniel J. F. M. Thuijs, Ricardo P. J. Budde

https://www.sciencedirect.com/science/article/pii/S1043067920303002/pdfft?md5=fbdc230bc84aea354b26e2f489b96dcc&pid=1-s2.0-S1043067920303002-main.pdf

42. Transcriptome network analyses in human coronavirus infections suggest a rational use of immunomodulatory drugs for COVID-19 therapy

Genomics, 20 January 2021, Volume 113, Issue 2, Pages 564-575

Henry Sung-Ching Wong, Chin-Lin Guo, Wei-Chiao Chang

https://www.sciencedirect.com/science/article/abs/pii/S0888754321000252

43. Comparative Analysis of Nanomechanical Features of Coronavirus Spike Proteins and Correlation with Lethality and Infection Rate

Matter, 2 November 2020, Volume 4, Issue 1 (Cover date: 6 January 2021), Pages 265-275

Yiwen Hu, Markus J. Buehler

https://www.sciencedirect.com/science/article/abs/pii/S2590238520306160

44. Comparative Host Interactomes of the SARS-CoV-2 Nonstructural Protein 3 and Human Coronavirus Homologs

Molecular & Cellular Proteomics, 27 June 2021, Volume 20, Article 100120

Katherine M. Almasy, Jonathan P. Davies, Lars Plate

https://www.sciencedirect.com/science/article/pii/S153594762100092X/pdfft?md5=acb99534e09b6268349d0027c105a5f9&pid=1-s2.0-S153594762100092X-main.pdf

45. Antibody profile in symptomatic/asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected Saudi persons

Saudi Journal of Biological Sciences, 3 May 2021, Volume 28, Issue 8, Pages 4677-4682

Essam H. Ibrahim, Mohammad Y. Alshahrani, Mona Kilany

https://www.sciencedirect.com/science/article/pii/S1319562X2100351X/pdfft?md5=0be1c5aaa564942ca4d482225de05c39&pid=1-s2.0-S1319562X2100351X-main.pdf

46. Hydrothermotherapy in prevention and treatment of mild to moderate cases of COVID-19

Medical Hypotheses, 16 November 2020, Volume 146 (Cover date: January 2021), Article 110363

Francisco E. Ramirez, Albert Sanchez, Aki T. Pirskanen

https://www.sciencedirect.com/science/article/pii/S0306987720332540/pdfft?md5=a70b4d9b49ed3b4b88fbd8e057791f3d&pid=1-s2.0-S0306987720332540-main.pdf

47. Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and meta-regression

Diabetes Research and Clinical Practice, 28 August 2021, Volume 179, Article 109031

Timotius Ivan Hariyanto, Denny Intan, Andree Kurniawan

https://www.sciencedirect.com/science/article/pii/S0168822721003909/pdfft?md5=7a6a0b77e8c82ec55a5611ef99dff61c&pid=1-s2.0-S0168822721003909-main.pdf

48. Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection

Microbial Pathogenesis, 3 November 2020, Volume 152 (Cover date: March 2021), Article 104554

Hossein Khorramdelazad, Mohammad Hossein Kazemi, Reza Falak

https://www.sciencedirect.com/science/article/abs/pii/S0882401020309207

49. Vertical transmission and kidney damage in newborns whose mothers had coronavirus disease 2019 during pregnancy

International Journal of Antimicrobial Agents, 9 December 2020, Volume 57, Issue 2 (Cover date: February 2021), Article 106260

Zheng He, Yinian Fang, Dong Liu

https://www.sciencedirect.com/science/article/abs/pii/S0924857920304805

50. Seroprevalence of neutralizing antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among healthcare workers in Makkah, Saudi Arabia

Journal of King Saud University - Science, 13 February 2021, Volume 33, Issue 3, Article 101366

Waleed A. Ahmed, Ashraf Dada, Esam I. Azhar

https://www.sciencedirect.com/science/article/pii/S1018364721000276/pdfft?md5=b2354dc145e5a25362a94e1ce16bf29d&pid=1-s2.0-S1018364721000276-main.pdf

PUBMED:

1. A human coronavirus evolves antigenically to escape antibody immunity

Eguia RT, Crawford KHD, Stevens-Ayers T, Kelnhofer-Millevolte L, Greninger AL, Englund JA, Boeckh MJ, Bloom JD.

PLoS Pathog. 2021 Apr 8;17(4):e1009453                                       

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8031418/pdf/ppat.1009453.pdf

2. Sustained Responses of Neutralizing Antibodies Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Recovered Patients and Their Therapeutic Applicability

Kim YS, Aigerim A, Park U, Kim Y, Park H, Rhee JY, Choi JP, Park WB, Park SW, Kim Y, Lim DG, Choi JY, Jeon YK, Yang JS, Lee JY, Shin HS, Cho NH.

Clin Infect Dis. 2021 Aug 2;73(3):e550-e558

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499518/pdf/ciaa1345.pdf

3. Sub-second heat inactivation of coronavirus using a betacoronavirus model

Jiang Y, Zhang H, Wippold JA, Gupta J, Dai J, de Figueiredo P, Leibowitz JL, Han A.

Biotechnol Bioeng. 2021 May;118(5):2067-2075

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013827/pdf/BIT-9999-0.pdf

4. Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues

Persoons L, Vanderlinden E, Vangeel L, Wang X, Do NDT, Foo SC, Leyssen P, Neyts J, Jochmans D, Schols D, De Jonghe S.

Antiviral Res. 2021 Sep;193:105127

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247284/pdf/main.pdf

5. Increased survivability of coronavirus and H1N1 influenza virus under electrostatic aerosol-to-hydrosol sampling

Piri A, Kim HR, Park DH, Hwang J.

J Hazard Mater. 2021 Jul 5;413:125417.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879034/pdf/main.pdf

6. Specificity and Mechanism of Coronavirus, Rotavirus, and Mammalian Two-Histidine Phosphoesterases That Antagonize Antiviral Innate Immunity

Asthana A, Gaughan C, Dong B, Weiss SR, Silverman RH.

mBio. 2021 Aug 31;12(4):e0178121.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406329/pdf/mbio.01781-21.pdf

7. Potential Protection of Pre-Existent Antibodies to Human Coronavirus 229E on COVID-19 Severity

Guzmán-Martínez O, Guardado K, Varela-Cardoso M, Trujillo-Rivera A, Gómez-Ñañez I, Ortiz-León MC, Espinosa R, Ramos C, Pérez-Carreón JI, López-Guerrero DV, Sampieri CL, Alanís-García AB, Rojas-Durán F, Zenteno-Cuevas R, Gutiérrez M, Montero H.

Int J Environ Res Public Health. 2021 Aug 27;18(17):9058

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430483/pdf/ijerph-18-09058.pdf

8. Development and Application of Human Coronavirus Protein Microarray for Specificity Analysis

Du PX, Chou YY, Santos HM, Keskin BB, Hsieh MH, Ho TS, Wang JY, Lin YL, Syu GD.

Anal Chem. 2021 Jun 1;93(21):7690-7698.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146142/pdf/ac1c00614.pdf

9. Updated and Validated Pan-Coronavirus PCR Assay to Detect All Coronavirus Genera

Holbrook MG, Anthony SJ, Navarrete-Macias I, Bestebroer T, Munster VJ, van Doremalen N.

Viruses. 2021 Apr 1;13(4):599

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067199/pdf/viruses-13-00599.pdf

10. Critical ACE2 Determinants of SARS-CoV-2 and Group 2B Coronavirus Infection and Replication

Adams LE, Dinnon KH 3rd, Hou YJ, Sheahan TP, Heise MT, Baric RS.

mBio. 2021 Mar 16;12(2):e03149-20

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092278/pdf/mBio.03149-20.pdf

SPRINGER NATURE

1. Sudden Sensorineural Hearing Loss Post Coronavirus Disease: A Systematic Review of Case Reports

Abishek Umashankar, Praveen Prakash… in Indian Journal of Otolaryngology and Head … (2021)

https://link.springer.com/content/pdf/10.1007%2Fs12070-021-02756-w.pdf

2. Analysis of the Genomic Distance Between Bat Coronavirus RaTG13 and SARS-CoV-2 Reveals Multiple Origins of COVID-19

Shaojun Pei 裴少君, Stephen S.-T. Yau 丘成栋 in Acta Mathematica Scientia (2021)

https://link.springer.com/content/pdf/10.1007%2Fs10473-021-0323-x.pdf

3. Deep Learning in Classification of Covid-19 Coronavirus, Pneumonia and Healthy Lungs on CXR and CT Images

Mihaela-Ruxandra Lascu in Journal of Medical and Biological Engineering (2021)

https://link.springer.com/content/pdf/10.1007%2Fs40846-021-00630-2.pdf

4. Quantitative analysis based on chest CT classifies common and severe patients with coronavirus disease 2019 pneumonia in Wuhan, China

Chongtu Yang, Guijuan Cao, Fen Liu, Jiacheng Liu… in Chinese Journal of Academic Radiology (2021)

https://link.springer.com/content/pdf/10.1007%2Fs42058-021-00061-7.pdf

5. Killer immunoglobulin-like receptor 2DS5 is associated with recovery from coronavirus disease 2019

Vadim Lesan, Moritz Bewarder, Carlos Metz… in Intensive Care Medicine Experimental (2021)

https://link.springer.com/content/pdf/10.1186%2Fs40635-021-00409-4.pdf

6. Hemodialysis patients with coronavirus disease 2019: reduced antibody response

Hiroko Beppu, Tatsuya Fukuda, Tomoko Kawanishi… in Clinical and Experimental Nephrology (2021)

https://link.springer.com/content/pdf/10.1007%2Fs10157-021-02130-8.pdf

7. Neurological manifestations of coronavirus disease 2019: exploring past to understand present

Ishita Desai, Rajat Manchanda, Niraj Kumar, Ashutosh Tiwari… in Neurological Sciences (2021)

https://link.springer.com/content/pdf/10.1007%2Fs10072-020-04964-8.pdf

8. Glycemic status affects the severity of coronavirus disease 2019 in patients with diabetes mellitus: an observational study of CT radiological manifestations using an artificial intelligence algorithm

Xiaoting Lu, Zhenhai Cui, Feng Pan, Lingli Li, Lin Li, Bo Liang… in Acta Diabetologica (2021)

https://link.springer.com/content/pdf/10.1007%2Fs00592-020-01654-x.pdf

9. Extracorporeal Membrane Oxygenation Therapy for Critically Ill Coronavirus Disease 2019 Patients in Wuhan, China: A Retrospective Multicenter Cohort Study

Jing Fang, Rui Li, Yue Chen, Juan-juan Qin, Ming Hu… in Current Medical Science (2021)

https://link.springer.com/content/pdf/10.1007%2Fs11596-021-2311-8.pdf

10. Drug screening and development from the affinity of S protein of new coronavirus with ACE2

Yue-Peng Jiang, Xiao-Xuan Zhao, Hui-Qing Lv… in European Journal of Clinical Microbiology y & Infectious Diseases (2021)

https://link.springer.com/content/pdf/10.1007%2Fs10096-020-04048-7.pdf

Các công bố về COVID-19 trước thời gian trên:

Cập nhật các công bố về COVID-19 từ ngày 27/08 đến ngày 03/09/2021

https://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-27-8-den-ngay-3-9-2021-3953.html

Cập nhật các công bố về COVID-19 từ ngày 20/08 đến ngày 27/08/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-20-8-den-ngay-27-8-2021-3932.html

Cập nhật các công bố về COVID-19 từ ngày 13/08 đến ngày 20/08/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-13-8-den-ngay-20-8-2021-3904.html

Cập nhật các công bố về COVID-19 từ ngày 06/08 đến ngày 13/08/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-6-8-den-ngay-13-8-2021-3878.html

Cập nhật các công bố về COVID-19 từ ngày 30/07 đến ngày 06/08/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-30-7-den-ngay-6-8-2021-3849.html

Cập nhật các công bố về COVID-19 từ ngày 23/07 đến ngày 30/07/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-23-7-den-ngay-30-7-2021-3823.html

Cập nhật các công bố về COVID-19 từ ngày 16/07 đến ngày 23/07/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-16-07-den-ngay-23-07-2021-3797.html

Cập nhật các công bố về COVID-19 từ ngày 09/07 đến ngày 16/07/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-09-07-den-ngay-16-07-2021-3769.html

Cập nhật các công bố về COVID-19 từ ngày 02/07 đến ngày 09/07/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-02-7-2021-den-ngay-9-7-2021-3744.html

Cập nhật các công bố về COVID-19 từ ngày 25/06 đến ngày 02/07/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-25-6-den-ngay-02-7-2021-3716.html

Cập nhật các công bố về COVID-19 từ ngày 18/06 đến ngày 25/06/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-18-6-den-ngay-25-6-2021-3692.html

Cập nhật các công bố về COVID-19 từ ngày 11/06 đến ngày 18/06/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-11-06-den-ngay-18-06-2021-3663.html

Cập nhật các công bố về COVID-19 từ ngày 04/06 đến ngày 11/06/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-04-06-den-ngay-11-6-2021-3642.html

Cập nhật các công bố về COVID-19 từ ngày 28/05 đến ngày 04/06/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-28-05-den-ngay-04-06-2021-3624.html

Cập nhật các công bố về COVID-19 từ ngày 21/05 đến ngày 28/05/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-21-05-den-ngay-28-05-2021-3598.html

Cập nhật các công bố về COVID-19 từ ngày 14/05 đến ngày 21/05/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-14-05-den-ngay-21-05-2021-3582.html

Cập nhật các công bố về COVID-19 từ ngày 07/05 đến ngày 14/05/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-07-05-den-ngay-14-05-2021-3557.html

Cập nhật các công bố về COVID-19 từ ngày 30/04 đến ngày 07/05/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-30-04-den-ngay-07-05-2021-3530.html

Cập nhật các công bố về COVID-19 từ ngày 23/04 đến ngày 30/04/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-23-04-den-ngay-30-04-2021-3509.html

Cập nhật các công bố về COVID-19 từ ngày 16/04 đến ngày 23/04/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-16-04-den-ngay-23-04-2021-3484.html

Cập nhật các công bố về COVID-19 từ ngày 09/04 đến ngày 16/04/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-09-04-den-ngay-19-04-2021-3474.html

Cập nhật các công bố về COVID-19 từ ngày 02/04 đến ngày 09/04/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-02-04-den-ngay-09-04-2021-3432.html

Cập nhật các công bố về COVID-19 từ ngày 26/03 đến ngày 02/04/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-26-03-den-ngay-02-04-2021-3408.html

Cập nhật các công bố về COVID-19 từ ngày 19/03 đến ngày 26/03/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-19-03-den-ngay-26-03-2021-3386.html

Cập nhật các công bố về COVID-19 từ ngày 12/03 đến ngày 19/03/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-12-3-den-ngay-19-3-2021-3376.html

Cập nhật các công bố về COVID-19 từ ngày 26/02 đến ngày 04/03/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-26-02-den-ngay-4-3-2021-3336.html

Cập nhật các công bố về COVID-19 từ ngày 09/02 đến ngày 25/02/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-09-02-den-ngay-25-02-2021-3319.html

Cập nhật các công bố về COVID-19 từ ngày 23/01 đến ngày 29/01/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-23-01-den-ngay-29-01-2021-3250.html

Cập nhật các công bố về COVID-19 từ ngày 09/01 đến ngày 15/01/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-09-01-den-ngay-15-01-2021-3211.html

Cập nhật các công bố về COVID-19 từ ngày 18/12 đến ngày 24/12/2020

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-18-12-den-ngay-24-12-2020-3174.html

Cập nhật các công bố về COVID-19 từ ngày 05/12 đến ngày 17/12/2020

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-05-12-den-ngay-17-12-2020-3160.html

Cập nhật các công bố về COVID-19 từ ngày 15/11 đến ngày 22/11/2020

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-15-11-den-ngay-22-11-2020-3123.html

Cập nhật các công bố về COVID-19 từ ngày 02/10 đến ngày 09/11/2020

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-02-10-den-ngay-09-11-2020-3107.html

Cập nhật các công bố về COVID-19 từ ngày 26/9 đến ngày 02/10/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-26-9-den-ngay-02-10-2020-3027.html

Cập nhật các công bố về COVID-19 từ ngày 19/9 đến ngày 25/9/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-19-9-den-ngay-25-9-2020-3010.html

Cập nhật các công bố về COVID-19 từ ngày 05/9 đến ngày 11/9/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-05-9-den-ngay-11-9-2020-2969.html

Cập nhật các công bố về COVID-19 từ ngày 29/8 đến ngày 04/9/2020

http://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-29-8-den-ngay-04-9-2020-2944.html

Cập nhật các công bố về COVID-19 từ ngày 21/8 đến ngày 28/8/2020

http://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-21-8-den-ngay-28-8-2020-2929.html

Cập nhật các công bố về VACCINE COVID-19 tháng 8 năm 2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-vaccine-covid-19-2900.html

Cập nhật các công bố về COVID-19 từ ngày 08/8 đến ngày 14/8/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-08-8-den-ngay-14-8-2020-2866.html

Cập nhật các công bố về COVID-19 từ ngày 27/7 đến ngày 07/8/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-27-7-den-ngay-07-8-2020-2826.html

Cập nhật các công bố về COVID-19 từ ngày 15/7 đến ngày 26/7/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-15-7-den-ngay-26-7-2020-2779.html

Cập nhật các công bố về COVID-19 từ ngày 05/7 đến ngày 13/7/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-05-7-den-ngay-13-7-2020-2723.html

Cập nhật các công bố về COVID-19 từ ngày 22/6 đến ngày 30/6/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-22-6-den-ngay-30-6-2020-2681.html

Cập nhật các công bố về COVID-19 từ ngày 15/6 đến ngày 21/6/2020

https://www.most.gov.vn/vn/tin-tuc/17959/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-15-6-den-ngay-21-6-2020.aspx

Cập nhật các công bố về COVID-19 từ ngày 07/6 đến ngày 14/6/2020

http://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-07-6-den-ngay-14-6-2020-2580.html

Cập nhật các công bố về COVID-19 đến ngày 07/6/2020

http://www.vista.gov.vn/news/khoa-hoc-ky-thuat-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-01-6-den-ngay-07-6-2020-2553.html

Cập nhật các công bố về COVID-19 đến ngày 01/6/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-den-ngay-01-6-2020-2524.html

Cập nhật các công bố về COVID-19 từ ngày 15/5 tới ngày 21/5/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-15-5-den-ngay-24-5-2020-2478.html

Cập nhật các công bố về COVID-19 từ ngày 08/5 tới ngày 14/5/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-08-5-den-ngay-14-5-2020-2436.html

Cập nhật các công bố về COVID-19 từ ngày 30/4 tới ngày 07/5/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-30-4-den-ngay-07-5-2020-2406.html

Cập nhật các công bố về COVID-19 từ ngày 24/4 tới ngày 30/4/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-24-4-den-ngay-30-4-2020-2375.html

Cập nhật các công bố về COVID-19 từ ngày 17/4 tới ngày 23/4/2020

https://www.most.gov.vn/vn/tin-tuc/17695/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-17-4-den-ngay-23-4-2020.aspx

Cập nhật các công bố về COVID-19 từ ngày 10/4 tới ngày 16/4/2020

https://www.most.gov.vn/vn/tin-tuc/17655/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-10-4--den-ngay-16-4-2020.aspx

Cập nhật các công bố về COVID-19 từ ngày 03/4 tới ngày 09/4/2020

https://www.most.gov.vn/vn/tin-tuc/17630/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-3-4--den-ngay-9-4-2020.aspx

Cập nhật các công bố về COVID-19 từ ngày 27/3 tới ngày 02/4/2020

https://www.most.gov.vn/vn/tin-tuc/17609/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-27-3-den-ngay-02-4-2020.aspx

Cập nhật các công bố về COVID-19 từ ngày 20/3 tới ngày 26/3/2020

https://www.most.gov.vn/vn/tin-tuc/17597/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-20-3-den-ngay-26-3-2020.aspx

Cập nhật các công bố về COVID-19 từ ngày 13/3 tới ngày 19/3/2020

https://www.most.gov.vn/vn/tin-tuc/17575/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-13-3-den-ngay-19-3-2020.aspx

Cập nhật các công bố về COVID-19 từ ngày 06/3 tới ngày 12/3/2020

https://www.most.gov.vn/vn/tin-tuc/17547/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-06-3-den-ngay-12-3-2020.aspx

Cập nhật các công bố về COVID-19 từ ngày 28/02 tới ngày 05/3/2020

http://www.vista.gov.vn/UserPages/News/detail/tabid/73/newsid/20781/language/vi-VN/Default.aspx?seo=Cap-nhat-cac-cong-bo-moi-ve-COVID-19-den-ngay-05/3/2020&language=vi-VN

Cập nhật các công bố về COVID-19 từ ngày 11/02 tới ngày 27/02/2020

http://www.vista.gov.vn/UserPages/News/detail/tabid/73/newsid/20740/seo/20740/language/vi-VN/language/vi-VN/Default.aspx

Cập nhật các công bố về virus corona từ tháng 11/2019 tới ngày 10/02/2020 

http://www.vista.gov.vn/UserPages/News/detail/tabid/73/newsid/20678/seo/20678/language/vi-VN/Default.aspx

Theo Cục Thông tin KH&CN Quốc gia, 17/9/2021